CA9 and cancer: Some of the reported derivatives, such as 37 and 38 (Figure 13) showed nanomolar CA IX/XII and COX-2 inhibitory action and micromolar inhibition of 15-LOX, and possessed effective antiproliferative action against hepatic (HepG2), breast (MCF7) and lung (A549) cancer cell lines.71